More companies have been added to an FDA recall of blood pressure medicine containing a possible carcinogen.

Click or tap here to see the updated list, which expands upon the original valsartan-containing drugs to at least 40 products with varying pill counts.

An impurity called N-nitrosodimethylamine (NDMA) was found in the drugs. NDMA is classified as a probable human carcinogen based on lab tests.

Earlier: FDA recalls blood pressure, heart failure medications after finding of cancer-causing impurity

The FDA says the list now includes valsartan-containing products manufactured by Hetero Labs Limited, in India, labeled as Camber Pharmaceuticals Inc.

Make it easy to keep up-to-date with more stories like this. Download the 10 News app now.

Have a news tip? Email tips@wtsp.com, visit our Facebook page or Twitter feed.